Evaluation of efficacy and safety of manidipine hydrochloride among essential hypertensive patients - Substitution from branded product (Calslot®) to generic product (Manidip®)

Yakugaku Zasshi

Volumn 127, Issue 12, 2007, Pages 2045-2050

  Kobayashi, Hiroko ^a   Obara, Taku ^b   Takahashi, Norio ^a   Takahashi, Takeshi ^a   Igari, Yukie ^a   Oikawa, Takuya ^b   Saito, Shinichiro ^a   Ohkubo, Takayoshi ^b   Imai, Yutaka ^b   Takahashi, Masanobu ^a  

^a Sendai Postal Services Agency Hospital   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Drug compliance; Efficacy; Generic product; Manidipine hydrochloride; Retrospective study; Safety

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; GENERIC DRUG; MANIDIP; MANIDIPINE; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; DRUG EFFICACY; DRUG INFORMATION; DRUG SAFETY; DRUG SCREENING; DRUG USE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; MEDICAL RECORD; PATIENT COMPLIANCE; PRESCRIPTION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AGED; AGED, 80 AND OVER; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; DRUG ADMINISTRATION SCHEDULE; DRUGS, GENERIC; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; THERAPEUTIC EQUIVALENCY;

EID: 36849047855     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.127.2045     Document Type: Article

References (16)

1. Staessen J. A., Wang J. G., Thijs L., Lancet, 358, 1305-1315 (2001).
2. Japanese Society of Hypertension, Hypertens. Res., 29, S1-S105 (2006).
3. Obara T., Ohkubo T., Funahashi J., Kikuya M., Asayama K., Metoki H., Oikawa T., Hashimoto J., Totsune K., Imai Y., J. Hypertens., 23, 1653-1660 (2005).
4. Obara T., Kobayashi M., J. Ther., 89, 527-531 (2007).
5. Kono S., Kitao K., Kitaguchi S., Matsumoto H., Aketa T., Yagi K., Hirai M., J. Pharm. Health Care Sci., 32, 1152-1158 (2006).
6. Kokuryo T., Matsumoto N., Sugahara Y., Yamada S., Jpn. J. Pharm. Health Care Sci., 32, 912-916 (2006).
7. Ichimori S., Mimori S., Mimori K., Shinohara D., Tateyama M., Ther. Res., 27, 2271-2274 (2006).
8. Obara T., Medicament News, 1869, 6-7 (2006).
9. Hirano T., Prog. Med, 25, 2415-2417 (2005).
10. Grant R. W., O'Leary K. M., Weilburg J. B., Singer D. E., Meigs J. B., Arch. Intern. Med., 164, 2343-2348 (2004).
11. Flack J. M., Novikov S. V., Ferrario C. M., Eur. Heart. J., 17 Suppl, A16-A20 (1996).
12. Van Wijk B. L., Klungel O. H., Heerdink E. R., de Boer A., Ann. Pharmacother., 40, 15-20 (2006).
13. Shrank W. H., Hoang T., Ettner S. L., Glassman P. A., Nair K., DeLapp D., Dirstine J., Avorn J., Asch S. M., Arch. Intern. Med., 166, 332-337 (2006).
14. Imai Y., Ohkubo T., Hozawa A., Tsuji I., Matsubara M., Araki T., Chonan K., Kikuya M., Satoh H., Hisamichi S., Nagai K., J. Hypertens., 19, 179-185 (2001).
15. Honda Y., J. Jpn. Soc. Hosp. Pharm., 41, 259-262 (2005).
16. Iijima H., Kamei M., Koshimizu T., Shiragami M., Jpn. J. Pharm. Health Care Sci., 125, 739-747 (2005).